Sanofi sues Eli Lilly to halt Lantus biosimilar

10-07-2014

French pharmaceutical company Sanofi has sued Eli Lilly for infringing seven patents that cover its blockbuster diabetes drug Lantus (insulin glargine).


Sanofi, Eli Lilly, Lantus, Abasria, biosimilars

LSIPR